Navigation Links
Burnham researchers illuminate mechanisms that regulate DNA damage control and replication
Date:1/5/2009

LA JOLLA, Calif., January 5, 2008Scientists at Burnham Institute for Medical Research (Burnham) have demonstrated important new roles for the protein kinase complex Cdc7/Dbf4 or Cdc7/Drf1 (Ddk) in monitoring damage control during DNA replication and reinitiating replication following DNA repair. Since Ddk is often deregulated in human cancers, this new understanding of its role in DNA damage control could help shape new cancer therapies. The research was published in the December 24 issue of Molecular Cell.

Accurate DNA replication is essential for maintaining the stability of the genome. When errors occur, replication halts through a quality control process called the S-phase checkpoint. Replication is only restarted after the errors have been repaired. One of several proteins required for DNA replication, Ddk has long been thought to play an important role in the S-phase checkpoint, despite the lack of definitive evidence. In this study, Burnham researchers show that Ddk actively controls S-phase checkpoint signaling and plays a crucial role in triggering the re-initiation of DNA replication once damage has been repaired.

"This protein kinase complex is not only monitoring DNA replication, it's also monitoring the S-phase checkpoint," says Wei Jiang, Ph.D., the study's principal investigator. "If replication is accurate, then Ddk allows DNA synthesis to continue normally. If there is DNA damage, replication is halted at this checkpoint. The most important thing is to stop replication in order to allow for DNA repair and to avoid catastrophe for the cell. Our study demonstrates that Ddk not only activates the initiation of DNA replication, but it also monitors the checkpoint during DNA damage control and eventually overrides the checkpoint to re-initiates DNA replication."

These findings suggest a highly complex role for Ddk in DNA replication, S-phase checkpoint monitoring and DNA replication re-initiation after repair. The r
'/>"/>

Contact: Josh Baxt
jbaxt@burnham.org
858-795-5236
Burnham Institute
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Burnham and HeadNorth Foundation join forces to advance spinal cord research
2. Recent developments at Burnham Institute
3. Recent developments at the Burnham Institute
4. Relocation plan of metastatic cancer cells uncovered by Stanford researchers
5. Researchers at Columbia University Medical Center link blood sugar to normal cognitive aging
6. Researchers create smaller, brighter probe tailored for molecular imaging and tumor targeting
7. Nutritious fast-food kids meals are scarce, researchers find
8. UIC researchers hunting drugs for devastating parasitic disease
9. Indiana University researchers revisit male bisexuality
10. Breast cancer risk varies in young women with benign breast disease, Mayo Clinic researchers say
11. Mayo researchers find potential links between breast density and breast cancer risk

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...arkett Sports, the worldwide leader in sports surf...offering with a more complete and innovative range...sports flooring experts and the launch of www.tar...(PRWEB) November 9, 2009 -- Tarkett Sports, redesi... products includes hardwood and synthetic basketba...
(Date:11/9/2009)...Nov. 9 /PRNewswire-Asia-FirstCall/ -- Mindray Medi...developer, manufacturer and,marketer of medical de...dited,financial results for the third quarter and ...lights for Operations as of September 30, 2009, ...llion, an increase of, 3.1% over the third q...
(Date:11/9/2009)...RNewswire/ -- The Churchill Centre today announc...p to J.W. "Bill" Marriott for his lifelong commitm...e market practices and fostering an open and trans...receive his award at a ceremony and dinner on Tues...ns Hotel. ,, "This is a testament to how Bill ...
(Date:11/9/2009)...nlargement, study finds , , MONDAY, Nov....tor for left atrial enlargement, which increases t...a new study shows. , Atrial fibrillation is the...t rhythm or heartbeat). , Researchers analyzed...rmany who were followed for 10 years. The study au...
(Date:11/9/2009)...t both eye conditions are age-related, researchers... -- Cataract surgery doesn,t appear to speed the p...D), according to a new study that challenges the b...ns the other. , "Because both conditions are st... also have AMD," wrote Li Ming Dong, of Stony Broo...
Breaking Medicine News(10 mins):Health News:Tarkett Sports Launches Revamped Indoor Sports Flooring Division and New Indoor Website 2Health News:Mindray Announces Third Quarter 2009 Financial Results 2Health News:Mindray Announces Third Quarter 2009 Financial Results 3Health News:Mindray Announces Third Quarter 2009 Financial Results 4Health News:Mindray Announces Third Quarter 2009 Financial Results 5Health News:Mindray Announces Third Quarter 2009 Financial Results 6Health News:Mindray Announces Third Quarter 2009 Financial Results 7Health News:Mindray Announces Third Quarter 2009 Financial Results 8Health News:Mindray Announces Third Quarter 2009 Financial Results 9Health News:Mindray Announces Third Quarter 2009 Financial Results 10Health News:Mindray Announces Third Quarter 2009 Financial Results 11Health News:Mindray Announces Third Quarter 2009 Financial Results 12Health News:Mindray Announces Third Quarter 2009 Financial Results 13Health News:Mindray Announces Third Quarter 2009 Financial Results 14Health News:Mindray Announces Third Quarter 2009 Financial Results 15Health News:Mindray Announces Third Quarter 2009 Financial Results 16Health News:Mindray Announces Third Quarter 2009 Financial Results 17Health News:Mindray Announces Third Quarter 2009 Financial Results 18Health News:J.W. 'Bill' Marriott to Receive Churchill Centre Award For Leadership 2Health News:Cataract Surgery Doesn't Worsen Macular Degeneration: Study 2
...visor and speaker Michael Morgan is helping U.S., ...d Middle Eastern and Islamic investors, business, ...ts tap into one of the most active investment sour...ities for everyone to find new markets, partners a...
...HO: Myles Druckman, MD, a leading disease outbr... Dr. Druckman has been interviewed by, ... CNN, CNBC, and, The Washington Post, a... including:, * The WHO raising ...
...r. Joel Selanikio,s innovative technology is not o...ublic health system around the world. Merging his ...ne and public health with his business partner,s b...lth data in developing nations. Officially establi...
...Biosystems, Inc. (OTC Bulletin Board: WGBS), a lea...s systems, today announced the signing of a resear...nter scientists for WaferGen,s SmartChip(TM) Real-... for Genome Sciences and Policy at Duke Universit...
...n and Narrows Earnings Guidance to Upper End of Ra...Hospira, Inc. (NYSE: HSP ), a leading global spe...any, today reported results for the first quarter ...rtain specified items as described later in this p...
...Associates Outlines China ,s , Stimulus Plan a... has announced a $124 billion stimulus package t... calls for digital hospitalization, adoption of el...tual healthcare services that can help overcome di...
Other Medicine News:Health News:Global Advisor and Speaker Explains Middle East Investors, Politics, Culture 2Health News:Available for Interviews: Pandemic, Disease Outbreak Expert to Discuss Swine Flu 2Health News:Available for Interviews: Pandemic, Disease Outbreak Expert to Discuss Swine Flu 3Health News:Open source mobile technology software reinventing health care in developing countries 2Health News:Open source mobile technology software reinventing health care in developing countries 3Health News:Open source mobile technology software reinventing health care in developing countries 4Health News:WaferGen and Leading Academic Medical Center Establish Genotyping Research Collaboration to Validate SNPs in Breast Cancer Using SmartChip(TM) Real-Time PCR System 2Health News:WaferGen and Leading Academic Medical Center Establish Genotyping Research Collaboration to Validate SNPs in Breast Cancer Using SmartChip(TM) Real-Time PCR System 3Health News:WaferGen and Leading Academic Medical Center Establish Genotyping Research Collaboration to Validate SNPs in Breast Cancer Using SmartChip(TM) Real-Time PCR System 4Health News:WaferGen and Leading Academic Medical Center Establish Genotyping Research Collaboration to Validate SNPs in Breast Cancer Using SmartChip(TM) Real-Time PCR System 5Health News:Hospira Reports First-Quarter 2009 Results 2Health News:Hospira Reports First-Quarter 2009 Results 3Health News:Hospira Reports First-Quarter 2009 Results 4Health News:Hospira Reports First-Quarter 2009 Results 5Health News:Hospira Reports First-Quarter 2009 Results 6Health News:Hospira Reports First-Quarter 2009 Results 7Health News:Hospira Reports First-Quarter 2009 Results 8Health News:Hospira Reports First-Quarter 2009 Results 9Health News:Hospira Reports First-Quarter 2009 Results 10Health News:Hospira Reports First-Quarter 2009 Results 11Health News:Hospira Reports First-Quarter 2009 Results 12Health News:Hospira Reports First-Quarter 2009 Results 13Health News:Hospira Reports First-Quarter 2009 Results 14Health News:Hospira Reports First-Quarter 2009 Results 15Health News:Hospira Reports First-Quarter 2009 Results 16Health News:Hospira Reports First-Quarter 2009 Results 17Health News:Hospira Reports First-Quarter 2009 Results 18Health News:China Seeks to Transform Healthcare Sector with Information Technology 2
(Date:11/9/2009)...ov. 9 ISTA Pharmaceutica...nal results from the Company,s Bepreve(TM) (bepota...linical studies. These results were presented in ...American College of Allergy, Asthma & Immunolo...presentation titled, "Treatment of Ocular Itching ...
(Date:11/9/2009)... Mass., Nov. 9 Decision Resources,...firms for pharmaceutical and healthcare issues, fi...eceptor 2 (HER2) targeting therapies -- which incl...ippon Kayaku,s Tykerb/Tyverb -- were the highest-s...inued uptake of Herceptin and Tykerb/Tyverb and th...
(Date:11/9/2009)...PHIA, Nov. 9 Shire plc...ty biopharmaceutical company, today announced the ...ded Release Tablets in pharmacies across the Unite...peractivity Disorder ( ADHD ) in children and ad...mulation of guanfacine, is the first and only nons...
Breaking Medicine Technology:ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 2ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 3Sales of HER2-Targeting Agents for Breast Cancer, Including Herceptin and Tykerb/Tyverb, Will Grow by 3.3 Percent Annually from 2008 to 2018 2Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 2Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 3Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 4Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 5Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 6Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 7BCBSF to Cover the Administration of H1N1 Vaccination for All Members 57166 1BCBSF to Cover the Administration of H1N1 Vaccination for All Members 57166 2Research Councils UK sign groundbreaking MoU with Brazil 9928 1Research Councils UK sign groundbreaking MoU with Brazil 9928 2Research Councils UK sign groundbreaking MoU with Brazil 9928 3BioCryst Announces Partnerships for Peramivir for Influenza Outside the U S 57160 1BioCryst Announces Partnerships for Peramivir for Influenza Outside the U S 57160 2BioCryst Announces Partnerships for Peramivir for Influenza Outside the U S 57160 3BioCryst Announces Partnerships for Peramivir for Influenza Outside the U S 57160 4BioCryst Announces Partnerships for Peramivir for Influenza Outside the U S 57160 5
...y 15 Cytopia Limited,(ASX: CYT) today announced t...n on CYT997 at the 2008 Annual Meeting of the Amer...ccessible to the public via ASCO,s,website (http:...DT)., The oral presentation, entitled "Phase I ev... disrupting agent, in patients with advanced cance...
... Schering-Plough,Corporation (NYSE: SGP ), a lea...nic hepatitis C virus (HCV) infection, announced t...PEGINTRON(TM) (peginterferon alfa-2b) and,REBETOL(...s boceprevir, the,company,s investigational oral H...th annual Digestive Disease Week (DDW) meeting to ...
Other Medicine Technology:Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 2Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 3Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 4Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 5Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 6Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 7
FemoStop
VasoSeal VHD KIT 6
VasoSeal VHD KIT 4
Hemapatch Knitted
Medicine Products: